GUANGZHOU, China, March 24 /PRNewswire-Asia/ -- China Medicine Corporation , a developer, manufacturer and leading distributor in China of Western pharmaceuticals, traditional Chinese medicine products, other nutriceuticals, medical devices, and medical formulations, today announced that it will conduct a conference call at 9:00 a.m. Eastern Time on Monday, March 29, 2009 to discuss its fourth quarter and full year 2009 results.
Joining Mr. Senshan Yang, Chairman and Chief Executive Officer of China Medicine Corporation, will be Mr. Robert Lu, Interim Chief Financial Officer. The Company plans to issue its earnings press release prior to the call.
To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 1 866 800.8648. International callers should dial 1 617 614.2702, Conference Passcode: 584 578 41.
If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Monday, March 29, at 11:00 p.m. Eastern Time. To access the replay, dial 888-286-8010, international callers dial 617-801-6888, and enter the passcode of 173 99 619.
About China Medicine Corporation
China Medicine Corporation is a developer, manufacturer and leading distributor in China of Western pharmaceuticals, traditional Chinese medicine products, other nutriceuticals, medical devices, and medical formulations. The Company also has its research and development force for certain products it manufactures through OEM arrangement and distributes. The Company distributes its products to wholesale distributors including more than 300 hospitals and 500 medicine companies that sell to over 2,000 drug stores in 28 provinces throughout China. The Company actively develops a number of proprietary products for a variety of uses, including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company’s website at http://www.chinamedicinecorp.com
Cautionary Statement
This press release contains forward-looking statements concerning the Company’s business and products. The Company’s actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, the Company’s projections of Lifetech’s financial results in 2009 and 2010, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risk factors detailed in the Company’s reports filed with the Securities and Exchange Commission. China Medicine Corporation undertakes no duty to revise or update any forward-looking statement to reflect events or circumstances after the date of this release.
CONTACT: Robert Lu, Interim Chief Financial Officer of China Medicine
Corp., +86-20-8739-1718, konzern08@163.com; or Crocker Coulson, President
of CCG Investor Relations, +1-646-213-1915 (NY Office),
crocker.coulson@ccgir.com
Web site: http://www.chinamedicinecorp.com/
